NCT05092165View on ClinicalTrials.gov

Methylene Blue for the Prevention of Hypotension During Hemodialysis

PHASE2RecruitingINTERVENTIONAL
Enrollment

260

Participants

Timeline

Start Date

October 21, 2021

Primary Completion Date

August 31, 2025

Study Completion Date

December 31, 2025

Conditions
Acute Kidney InjuryShock
Interventions
DRUG

Methylene Blue

1 mg per kilogram bolus, followed by 0.1 milligram per kilogram during renal replacement therapy

OTHER

Control

Usual care during renal replacement therapy

Trial Locations (1)

04038002

RECRUITING

Federal University of São Paulo, São Paulo

All Listed Sponsors
lead

Federal University of São Paulo

OTHER